World's Best Scientists 2026 revealed!
P.L.C.M. van Riel

P.L.C.M. van Riel

D-Index & Metrics

Medicine

D-Index
86
Citations
39533
World Ranking
13890
National Ranking
528

Overview

P.L.C.M. van Riel is affiliated with Radboud University in the Netherlands and has a research focus primarily within the field of Medicine, with a significant emphasis on Rheumatology. Their work spans several subfields including Cardiology and Cardiovascular Medicine, Hematology, Hepatology, and Immunology.

The scientist's research topics include Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research, Hepatitis C virus research, Biosimilars and Bioanalytical Methods, Acute Myocardial Infarction Research, and Lymphoma Diagnosis and Treatment.

Major publication venues where P.L.C.M. van Riel has contributed include:

  • Annals of the Rheumatic Diseases
  • Rheumatology Advances in Practice
  • RMD Open
  • Mediterranean Journal of Rheumatology
  • Rheumatology International

Notable recent papers authored or co-authored by van Riel include:

  • "EULAR definition of difficult-to-treat rheumatoid arthritis," 2020, Annals of the Rheumatic Diseases
  • "EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis," 2021, Annals of the Rheumatic Diseases
  • "Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization," 2021, Rheumatology Advances in Practice
  • "Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit," 2021, RMD Open
  • "Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice," 2021, RMD Open

Their frequent co-authors comprise:

  • George D. Kitas
  • Silvia Rollefstad
  • Anne Grete Semb
  • Eirik Ikdahl
  • George Karpouzas

Best Publications

  • Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

    M.L.L. Prevoo;M.A. van 't Hof;H.H. Kuper;M.A. van Leeuwen

  • Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria

    A.M. van Gestel;M.L.L. Prevoo;M.A. van 't Hof;M.H. van Rijswijk

  • Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

    D M van der Heijde;M A van 't Hof;P L van Riel;L A Theunisse

  • A simplified disease activity index for rheumatoid arthritis for use in clinical practice

    J.S. Smolen;F.C. Breedveld;M.H. Schiff;J.R. Kalden

  • The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

    E.J.A. Kroot;B.A.W. de Jong;M.A. van Leeuwen;H.L. Swinkels

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.

    A.M. van Gestel;C.J. Haagsma;P.L.C.M. van Riel

  • Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

    G. Wells;J.C. Becker;J. Teng;M. Dougados

  • Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

    M.C.W. Creemers;M.J.A.M. Franssen;M.A. van 't Hof;F.W.J. Gribnau

  • The Disease Activity Score and the EULAR response criteria.

    J. Fransen;P.L.C.M. van Riel

  • Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

    L B A van de Putte;C Atkins;M Malaise;J Sany

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

    F. Buttgereit;J.A. da Silva;M. Boers;G.R. Burmester

  • Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

    J. Fransen;M.C.W. Creemers;P.L.C.M. van Riel

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

  • Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis : a randomized, controlled study

    R. F. J. M. Laan;P. L. C. M. Van Riel;L. B. A. Van De Putte;L. J. T. O. Van Erning

  • REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE

    M.L.L. Prevoo;A.M. van Gestel;M.A. van 't Hof;M.H. van Rijswijk

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

    T.R.D.J. Radstake;M. Svenson;A.M.M. Eijsbouts;F.H.J. van den Hoogen

  • Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

    D. M. F. M. Van Der Heijde;M. A. Van't Hof;P. L. C. M. Van Riel;M. A. Van Leeuwen

Frequent Co-Authors

L. B. A. Van De Putte
L. B. A. Van De Putte Radboud University
Pilar Barrera
Pilar Barrera Radboud University Nijmegen Medical Centre
Paul Emery
Paul Emery University of Leeds
Andrea W M Evers
Andrea W M Evers Leiden University
Gijs Bleijenberg
Gijs Bleijenberg Radboud University
Maxime Dougados
Maxime Dougados Hôpital Cochin
Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
George D. Kitas
George D. Kitas Dudley Group NHS Foundation Trust
Ferdinand C. Breedveld
Ferdinand C. Breedveld Leiden University Medical Center
Robert Landewé
Robert Landewé University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn't just mean becoming a doctor. There are many in-demand allied health and administrative roles you can pursue online. For example, those interested in the business side of healthcare may explore medical billing and coding financial aid options, which make training in this field both accessible and affordable.

If you aim to provide direct patient care but want a streamlined admissions process, consider nursing school without teas test requirements. These programs remove traditional testing barriers, helping you jumpstart your nursing journey sooner.

Those looking for leadership and management roles in healthcare can pursue a healthcare administration degree online accredited. These flexible programs prepare graduates for supervisory positions in hospitals, clinics, and public health organizations.

Already a nurse and looking to advance? Bridge programs like adn to np programs online help registered nurses earn advanced practice credentials, opening doors to higher earning potential and expanded clinical roles in the U.S. healthcare system.

Best Scientists Citing P.L.C.M. van Riel

Trending Scientists

Recently Published Articles